JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2020, Vol. 22 ›› Issue (5): 556-560.DOI: 10.3969/j.issn.1671-2587.2020.05.028
YANG Jun-hong, HUANG Xia, HE Tao, et al
Received:
2019-03-22
Online:
2020-10-20
Published:
2020-10-16
CLC Number:
YANG Jun-hong, HUANG Xia, HE Tao, et al. Research Progress of Heamovigilance in Adverse Reaction of Blood Donation[J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(5): 556-560.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.lcsxyjy.com/EN/10.3969/j.issn.1671-2587.2020.05.028
[1] 陈辉,徐健,郭瑾,等.国家卫生行业标准《献血不良反应分类指南》导读[J].中国输血杂志,2017,30(9):1080-1084. [2] 范亚欣,吴洁玲,孟庆丽,等.全国献血不良反应的调查与分析[J]. 中国输血杂志,2016,29(9):956-959. [3] 高波,周源,李永铭,等.我国献血不良反应监测管理现状[J]. 中国输血杂志,2018,31(9):974-977. [4] 崔伟慧. 献血不良反应对献血者再次献血的影响及护理要点分析[J].中国医药指南,2017,15(32):246-247. [5] 中国输血协会血液质量管理工作委员会.血液安全预警指南(第二版)[S].2015. [6] 国家卫生计生委.献血不良反应分类指南[S].WS/T 571-2017. [7] 国家卫生计生委. 献血相关血管迷走神经反应预防和处置指南[S]. WS/T 595-2018. [8] Working Group on Donor Vigilance of the International Society of Blood Transfusion,Working Party on Haemovigilance,in collaboration with The International Haemovigilance Network and The AABB Donor Haemovigilance Working Group. Standard forsurveillance of complications related to blood donatio[S].2014-12-11[2014-12-25].. Standard forsurveillance of complications related to blood donatio[S].2014-12-11[2014-12-25].http://www.isbtweb.org/working-parties/haemovigilance/definitions. [9] Goldman M,Land K,Robillard P,et al.Development of standard definitions for surveillance of complications related to blood donation[J].Vox Sang,2016,110(2):185-188. [10] 郭永建. 国际输血协会献血并发症监测标准(2014年修订版)主要内容及其启示[J].中国输血杂志,2015,28(2):223-229. [11] 中国输血协会血液质量管理工作委员会.血液安全预警指南(第一版)[S].2013. [12] 中国输血协会. 血液安全监测指南[S].T/CSBT 001-2019. [13] Daurat A,Roger C,Gris J,et al.Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors:a study from French hemovigilance data[J]. Transfusion,2016,56(6):1295-1303. [14] Eder AF,Dy BA,Kennedy JM,et al.The American Red Cross donor hemovigilance program:complications of blood donation reported in 2006[J]. Transfusion,2008,48(9):1809-1819. [15] Affiliated to the Royal College of Pathologists.The2017 Annual SHOT Report[EB/OL]. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Report-2017-WEB-Final-v4-25-9-18.pdf. [16] Inaba S,Takanashi M,Matsuzaki K,et al.Analysis of a questionnaire on adverse reactions to blood donation in Japan[J]. Transfus Apher Sci,2013,48(1):21-34. [17] Newman BH,Newman DT,Ahmad R,et al.The effect of whole-blood donor adverse events on blood donor return rates[J]. Transfusion,2006,46(8):1374-1379. [18] Tiwari AK,Aggarwal G,Dara RC,et al.Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions:First attempt in India[J]. Transfus Apher Sci, 2017,56(2):141-146. [19] Burkhardt T,Dimanski B,Karl R,et al.Donor vigilance data of a blood transfusion service:a multicenter analysis[J]. Transfus Apher Sci,2015,53(2):180-184. [20] Politis C,Wiersum JC,Richardson C,et al.The international haemovigilance network database for the surveillance of adverse reactions and events in donors and recipients of blood components:technical issues and results[J]. Vox Sang,2016,111(4):409-417. [21] Jorgensen J,Sorensen BS.Donor vigilance[J]. ISBT Sci Ser, 2008,3(1):48-53. [22] Newman BH,Newman DT,Ahmad R,et al.The effect of whole-blood donor adverse events on blood donor return rates[J]. Transfusion,2006,46(8):1374-1379. [23] Sultan S,Baig MA,Irfan SM,et al.Adverse reactions in allogeneic blood donors:a tertiary care experience from a developing country[J].Oman Med J,2016,31(2):124-128. [24] Rajbhandary S, Stubbs JR, Land KJ, Whitaker BI (eds).AABB Donor Hemovigilance Report: 2012-2014 on behalf of the AABB US Donor Hemovigilance Working Group [EB/OL].AABB Press, 2016. http://www.aabb.org/research/hemovigilance/Documents/2012-2014-AABB-Donor-Hemovigilance-Report.pdf. [25] Unidad de Hemovigilancia.HEMOVIGILANCIA AÑO 2016 [EB/OL]. 2017. http://www.msssi.gob.es/profesionales/saludPublica/medicinaTransfusional/hemovigilancia/docs/IInform2016.pdf. [26] Australian Haemovigilance Report, Data for2013-14 published by the National Blood Authority [EB/OL].2016. https://www.blood.gov.au/system/files/Australian-Haemovigilance-Report-2016.pdf. [27] Krishna Badami,John Dagger,William Murphy,et al. Annual Report2015 [EB/OL].2016. https://www.nzblood.co.nz/assets/Uploads/Haemovigilance-Annual-Report-2016.pdf. [28] Jackie Thomson,Gregory Bellairs,Caroline Hilton, et al.SANBS & WPBTS Haemovigilance Report2016 [EB/OL].2016.https://sanbs.org.za/wp-content/uploads/2017/12/SANBS-HV-Report_2016_Web-Version.pdf. [29] Eder AF,Hillyer CD,Dy BA,et al.Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds[J]. JAMA,2008,299(19):2279-2286. [30] Kamel H,Tomasulo P,Bravo M,et al.Delayed adverse reactions to blood donation[J]. Transfusion,2010,50(3):556-565. [31] Wiltbank TB,Giordano GF,Kamel H,et al.Faint and prefaint reactions in whole-blood donors:an analysis of predonation measurements and their predictive value[J]. Transfusion,2008,48(9):1799-1808. [32] Hanson SA,France CR.Predonation water ingestion attenuates negative reactions to blood donation[J]. Transfusion,2004,44(6):924-928. [33] Sauer LA.Caffeine attenuates vasovagal reactions in female first-time blood donors[J].Heal Psychol,1999,18(4):403-409. [34] Ditto B,France CR,Lavoie P,et al.Reducing reactions to blood donation with applied muscle tension:a randomized controlled trial[J]. Transfusion,2003,43(9):1269-1275. [35] Custer B,Rios JA,Schlumpf K,et al.Adverse reactions and other factors that impact subsequent blood donation visits[J]. Transfusion,2012,52(1):118-126. [36] Masser BM,White KM,Terry DJ.Beliefs underlying the intention to donate again among first-time blood donors who experience a mild adverse event[J]. Transfus Apher Sci,2013,49(2):278-284. [37] 国家卫生健康委员会办公厅.关于2017年全国血液安全技术核查情况的通报[EB/OL].国卫办医函〔2018〕346号. http://www.nhfpc.gov.cn/yzygj/s7658/201805/77ba80726c694b188e617f0d43d23856.shtml. |
[1] | JIA Yan-jun, ZHAO Xu-ying, WEI Zhen-zhen. Effects of Resveratrol on Platelet Oxidative Stress and Aging Index and Storage Time [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 137-141. |
[2] | WANG Lei, WU Xue-zhong. Retrospective Analysis of Rh (D,C, c, E, e) Antigens Compatibility between Blood Recipients and Donors [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 181-185. |
[3] | GAN Shan, DUAN Ling, HU Hong-bing. The Clinical Use of Blood in Exchange Transfusion for Severe Neonatal Hyperbilirubinemia [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 185-188. |
[4] | DUAN Bing-zheng, WANG Shu-lian, LIAN Jun-hui, et al. Clinical Significance of Direct Anti-human Globulin Test in Patients' Blood Transfusion Effect [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 189-191. |
[5] | YANG Chun-chen, RONG Rui-ming, LI Yang, et al. An Evaluation Model of Clinical Blood Transfusion Records Based on Cov-AHP-fuzzy Comprehensive Evaluation Method [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 192-196. |
[6] | GUO Wei-jie, LIU Ze-ya, ZHANG Fan, et al. Meta-analysis:Unexpected Antibody Positive Rate of Blood Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 202-212. |
[7] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 236-239. |
[8] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 239-241. |
[9] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 248-255. |
[10] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 259-262. |
[11] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(2): 268-272. |
[12] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(1): 13-17. |
[13] | HAO Yi-wen. Evaluating Indications for Red Blood Cell Transfusion and Therapeutic Efficacy:An Overall and Dynamic View [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 590-593. |
[14] | HUANG Rong, CHEN Ting-ting, ZHU Long-fei, et al. Blood Transfusion in Maternal Neonatal Diseases [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 610-612. |
[15] | . [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2020, 22(6): 613-616. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||